Galmed Pharmaceuticals Announces Publication in “The Journal of Autoimmunity” for its IND ready, Amilo-5MER, a specific anti-inflammatory compound
August 19, 2021 12:00 pm Leave your thoughts– Amilo-5MER suppresses chronic inflammations in broad spectrum of animal models of inflammatory diseases.
Categorised in: Uncategorized
This post was written by admin